Assisted Reproductive Technology Global Market Sees Growth Rate Of 19% Through 2022
25 Jan, 2022
The global assisted reproductive technology market size is expected to grow from $26.28 billion in 2021 to $31.29 billion in 2022 at a compound annual growth rate (CAGR) of 19.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $62.05 billion in 2026 at a CAGR of 18.7%.
What is the Global Assisted Reproductive Technology Market?
The ART market consists of sales of assisted reproductive technology by entities (organizations, sole traders, and partnerships) that are used for the treatment of infertility in either eggs or embryos. Assisted reproductive technology is based on the surgically removing of eggs from women’s ovaries and then fusing it with men’s sperm in the laboratory to create embryos. These embryos are then inserted back into the women’s body. ART uses donor eggs, donor sperms, or previously stored frozen embryos.
Get a Sample of the global assisted reproductive technology market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&&type=smp
What drives the Global Assisted Reproductive Technology Market?
The rising number of infertility cases is expected to foster the assisted reproductive technology market in the coming years. Infertility is defined as the failure to become pregnant after a year of frequent and unprotected intercourse. Infertility affects both men and women, and is typically diagnosed by the inability to conceive. Infertility is treated using ART. Fertility therapies that work with both a woman's egg and a man's sperm are included in this. For instance, according to the UCLA Health, a US based health system, in 2020 around 15% of couples in the world have trouble in conceiving. Infertile couples are increasingly turning to assisted reproductive technology, which is growing at a rate of 5% to 10% every year. Therefore, the rising number of infertility cases drives the growth of the assisted reproductive technology market.
Get the full global assisted reproductive technology industry report here:
https://www.thebusinessresearchcompany.com/report/assisted-reproductive-technology-global-market-reportGlobal Assisted Reproductive Technology Market Segments
The global assisted reproductive technology market is segmented:
By Diagnosis: Ovulation Testing, Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing
By Procedure Type: Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking
By End-User: Hospitals, Fertility Clinics, Others
By Geography: The regions covered in the assisted reproductive technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Among these regions, Europe accounts for the largest share in the global assisted reproductive technology market.
Assisted Reproductive Technology Global Market Report 2022provides market size and growth forecasts for the global assisted reproductive technology market, global assisted reproductive technology market share, assisted reproductive technology market segments and geographies, assisted reproductive technology market competitive landscape including leading competitors’ revenues, profiles and market shares. The assisted reproductive technology market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Assisted Reproductive Technology Industry Playersinclude Cooper Surgical Inc., Ferring B.V., Hamilton Thorne Ltd, Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific, Boston Science Corporation, Anecova, Carolinas Fertility Institute, Microm Ltd. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.